Comparing Bijuva vs Veozah
Bijuva (estradiol / progesterone) | Veozah (fezolinetant) |
|
---|
Bijuva (estradiol / progesterone) | Veozah (fezolinetant) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Perimenopausal Symptoms, Postmenopausal Symptoms, Menopausal Disorders, Hot Flashes. Bijuva may also be used for purposes not listed in this medication guide. |
Prescription only
Veozah may be used to treat moderate to severe vasomotor symptoms of menopause such as hot flashes and night sweats. It is taken as an oral tablet, once daily but cannot be taken by women with... View more |
Related suggestions Hot Flashes
Menopausal Disorders
|
|||||||||||||||
More about Bijuva (estradiol / progesterone) | More about Veozah (fezolinetant) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Bijuva has an average rating of 6.0 out of 10 from a total of 49 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 27% reported a negative effect. |
Veozah has an average rating of 7.6 out of 10 from a total of 42 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 5% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Bijuva side effects |
View all Veozah side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Bijuva prices |
View all Veozah prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
26.47 hours |
9.6 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 415 drugs are known to interact with Bijuva:
|
A total of 93 drugs are known to interact with Veozah:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
|
|||||||||||||||||
First Approval Date | |||||||||||||||||
October 28, 2018 |
May 12, 2023 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Prometrium
Prometrium is a female hormone used to cause menstrual periods in women who have not yet reached ...
Osphena
Osphena (ospemifene) is used to relieve pain during sexual intercourse in menopausal women. Learn ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Endometrin
Endometrin is used in fertility treatment for women with low levels of natural progesterone ...
Crinone
Crinone is used for amenorrhea, endometrial hyperplasia, prophylaxis, perimenopausal symptoms ...
Prochieve
Prochieve is used for amenorrhea, endometrial hyperplasia, prophylaxis, perimenopausal symptoms ...
Ospemifene
Ospemifene is used for atrophic vaginitis, dyspareunia, perimenopausal symptoms, postmenopausal ...
Progesterone
Progesterone is a female hormone important for the regulation of ovulation and menstruation ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.